Neuropathology and Applied Neurobiology · 2022 · 21 citations · 31 references
MedicinePathobiologyPathologyHistologyHistopathologyImmunopathologyFibrosisIdiopathic Inflammatory MyopathiesMuscle PathologySystemic SclerosisAutoimmune MyositisBasement Membrane DysfunctionDisease SubsetsEarly Systemic SclerosisHistopathological EvaluationHistopathological LesionsImmunofluorescence FindingsPericyte Loss
AIMS: We aim to perform ultrastructural and histopathological analysis of muscle biopsies from a large group of systemic sclerosis (SSc) patients, including some with early/mild SSc features, and examine whether capillary pathology differentiates 'scleromyositis' (SM) from other auto-immune myositis (AIM) subsets. METHODS: Muscle biopsies from a total of 60 SM patients and 43 AIM controls from two independent cohorts were examined by electron microscopy, collagen-4 immunofluorescence (Col4IF) and routine light microscopy. RESULTS: Ultrastructural examination revealed prominent capillary basement membrane (BM) reduplication (4+ layers in >50% of capillaries) in 65% of SM vs 0% of AIM controls (p < 0.001). In SM cases without prominent BM reduplication, capillary dilation was the most distinctive feature, present in 8% of capillaries in SM vs 2% in controls (p = 0.001). Accumulation of ensheathed pericyte processes was another characteristic feature of SM and closely correlated with the degree of BM reduplication (r = 0.833, p < 0.001). On light microscopy, BM marker Col4IF revealed more frequent capillary enlargement in SM than in controls (84% vs 21%, p < 0.001). SM cases were classified as non-inflammatory myopathy (36%), non-specific myositis (33%) or immune-mediated necrotizing myopathy (31%), but despite this histopathological heterogeneity, prominent BM reduplication remained a constant finding. In the 16 SM patients with early/mild SSc features, 63% showed prominent BM reduplication. CONCLUSIONS: These results show that capillary pathology, and in particular prominent capillary BM reduplication, is the hallmark histopathological feature of SM even in patients with early/mild SSc and support the concept of SM as an organ manifestation of SSc and a distinct subset of AIM.
31
F.H.J. van den Hoogen, Dinesh Khanna, Jaap Fransen et al. · Annals of the Rheumatic Diseases · 2013 · 2.9K citations
Ingrid E. Lundberg, Anna Tjärnlund, Matteo Bottai et al. · Annals of the Rheumatic Diseases · 2017 · 1.5K citations · Full text
Medicine, Dermatology, Pediatrics +13
Jessica E. Hoogendijk, Anthony A. Amato, Bryan Lecky et al. · Neuromuscular Disorders · 2004 · 937 citations
Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis
Steven A. Greenberg, Jack L. Pinkus, Geraldine S. Pinkus et al. · Annals of Neurology · 2005 · 612 citations
Medicine, Immunology, Pathology +17
Martial Koenig, France Joyal, Marvin J. Fritzler et al. · Arthritis & Rheumatism · 2008 · 602 citations